From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

Phase 3 results show the investigational drug norucholic acid is superior to placebo in halting disease progression.

The parasite, which claims nearly 70,000 lives each year, usually causes nothing more than diarrhoea, but sometimes it ...

The Liver Transplant Comorbidity Index, developed from FrAILT study results, identified patients at high risk for mortality at 3 years post-liver transplant.

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced two-year results from the open-label arm of ...

Poo can be different colours for many different reasons, including some which are entirely normal. But in some cases, it can ...

Liver diseases in children, often hereditary, present unique challenges, with conditions like biliary atresia, ...

Early menopause before age 50 significantly increases the risk of fatty liver disease and metabolic disorders, according to ...

California biotech NGM Bio is slimming down as the company pivots focus, shedding around 75% of staff, pausing development of ...

In the study population of more than 30,000 people without known liver disease, the proportion of persons with a liver ...

Aroosha Sarrafi tells Health her story of getting diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), a ...

From hidden sugars to sedentary afternoons, discover which everyday habits contribute to dangerous liver fat accumulation and ...